Merck & Co., Inc. has disclosed 12 total holdings in their latest 13F filing with the SEC for the portfolio
date of 2025-03-31. The current portfolio value is calculated to be $164.00 Mil. The turnover rate is 1%.
In Merck & Co., Inc.'s current portfolio as of 2025-03-31, the top 5 holdings are
Moderna Inc (MRNA), Personalis Inc (PSNL), Kymera Therapeutics Inc (KYMR), Entrada Therapeutics Inc (TRDA), Alector Inc (ALEC), not including call and put options.
Merck & Co., Inc. did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the current and past 13F holdings for Merck & Co., Inc., as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at
52-week lows, etc.
Please visit the "Stock Picks" tab to see the latest guru trades and stock picks for Merck & Co., Inc., which include data from
13F quarterly reports, 13D/G beneficial ownership reports and form 4 insider ownership change reports.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for Merck & Co., Inc..